Claude - holy jumping beans
Press release from Zonagen today - Mexican filing
=====================================================================
Thursday March 19, 8:32 am Eastern Time
Company Press Release
Zonagen Announces Product Registration Filed in Mexico for Vasomax
THE WOODLANDS, Texas--(BW HealthWire)--March 19, 1998-- Zonagen, Inc. (Nasdaq: ZONA; Pacific: ZNG) today announced that Schering-Plough Corporation (NYSE: SGP - news) has filed a Product Registration Application in Mexico for Vasomax(TM) for the treatment of Male Erectile Dysfunction (MED).
''The Product Registration Application in Mexico for Vasomax(TM) is an important step in the process of commercialization,'' said Joseph Podolski, president and chief operating officer of Zonagen.
Vasomax(TM), Zonagen's immediate-release oral formulation of phentolamine mesylate, was licensed worldwide to Schering-Plough in November 1997 for the treatment of MED. Vasomax has been tested in over 300 men in Mexico and more than 3,000 men in the U.S.
Zonagen, Inc. specializes in the development of products and services for the management of reproductive health. Its technologies focus on the areas of urology, female health and contraception. Through its wholly owned subsidiary, Fertility Technologies, Inc. (FTI), Zonagen sells devices, instruments and supplies to the fertility specialist and the OB/GYN.
This release may contain certain forward-looking statements, including statements regarding the clinical investigation, timing, approval and commercialization of products that involve a number of risks and uncertainties. Actual events or results may differ from the company's expectations as a result of risk factors identified in the Company's reports and registrations as filed with the U.S. Securities Exchange Commission.
=====================================================================
Amazing how Zonagen & SGP continue to waste time and money by pursuing the commercialization of this old, worthless compound. There must not be a SINGLE PERSON in either organization that can accurately assess the potential of their own drugs. Perhaps they could hire Asensio or Wexler as a consultant & avoid such amateurish mistakes in the future. |
